Skip to main content
Top

26-04-2024 | Peritoneal Dialysis | Case Report

Combining hemodialysis with peritoneal dialysis improves cognitive function: a three-case report

Authors: Tomomi Maruki, Takashin Nakayama, Kohkichi Morimoto, Kiyotaka Uchiyama, Naoki Washida, Ryunosuke Mitsuno, Shun Tonomura, Eriko Yoshida Hama, Ei Kusahana, Norifumi Yoshimoto, Akihito Hishikawa, Aika Hagiwara, Tatsuhiko Azegami, Jun Yoshino, Toshiaki Monkawa, Tadashi Yoshida, Shintaro Yamaguchi, Kaori Hayashi

Published in: CEN Case Reports

Login to get access

Abstract

Chronic kidney disease (CKD) is associated with multiple complications, with recent scholarly attention underscoring cognitive impairment as a salient manifestation. Considering societal aging, preserving cognitive function has emerged as an urgent medical concern. Prolonged dialysis, encompassing hemodialysis (HD) and peritoneal dialysis (PD), has been associated with a decline in cognitive function. Here, we present the cases of three patients undergoing PD who exhibited a noticeable improvement in cognitive function upon the initiation of HD. One patient had exhibited mild cognitive decline, whereas the remaining two presented more severe impairment. Apart from a mild tendency for fluid retention, none of the three patients exhibited abnormalities in physical or imaging examinations. Evaluation using the Japanese version of the Montreal Cognitive Assessment (MoCA-J) yielded decreased scores across multiple domains, notably in executive and attention functions. However, after HD initiation, all patients demonstrated a marked enhancement in multiple MoCA-J parameters, accompanied by a significant improvement in subjective symptoms. Moreover, improvements in anemia and hypoalbuminemia were observed in all three patients, whereas consistent trends in other parameters were absent. These clinical observations suggest that the integration of HD into the therapeutic regimen of patients undergoing PD may enhance cognitive function, highlighting the contributory roles of hemoglobin and albumin in CKD-associated cognitive impairment.
Literature
1.
go back to reference Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–69.CrossRefPubMed Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382:158–69.CrossRefPubMed
2.
go back to reference Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS ONE. 2016;11:e0158765.CrossRefPubMedPubMedCentral Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS ONE. 2016;11:e0158765.CrossRefPubMedPubMedCentral
3.
go back to reference Hanafusa N, Abe M, Joki N, Hoshino J, Kikuchi K, Goto S, et al. 2021 Annual dialysis data report, JSDT renal data registry. Nihon Toseki Igakkai Zasshi. 2022;55:665–723.CrossRef Hanafusa N, Abe M, Joki N, Hoshino J, Kikuchi K, Goto S, et al. 2021 Annual dialysis data report, JSDT renal data registry. Nihon Toseki Igakkai Zasshi. 2022;55:665–723.CrossRef
4.
go back to reference Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58:338–45.CrossRefPubMedPubMedCentral Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, et al. Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc. 2010;58:338–45.CrossRefPubMedPubMedCentral
5.
go back to reference Sarnak MJ, Tighiouart H, Scott TM, Lou KV, Sorensen EP, Giang LM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013;80:471–80.CrossRefPubMedPubMedCentral Sarnak MJ, Tighiouart H, Scott TM, Lou KV, Sorensen EP, Giang LM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013;80:471–80.CrossRefPubMedPubMedCentral
6.
go back to reference Bronas UG, Puzantian H, Hannan M. Cognitive impairment in chronic kidney disease: vascular milieu and the potential therapeutic role of Exercise. Biomed Res Int. 2017;2017:2726369.CrossRefPubMedPubMedCentral Bronas UG, Puzantian H, Hannan M. Cognitive impairment in chronic kidney disease: vascular milieu and the potential therapeutic role of Exercise. Biomed Res Int. 2017;2017:2726369.CrossRefPubMedPubMedCentral
7.
go back to reference McAdams-Demarco MA, Tan J, Salter ML, Gross A, Meoni LA, Jaar BG, et al. Frailty and cognitive function in incident hemodialysis patients. Clin J Am Soc Nephrol. 2015;10:2181–9.CrossRefPubMedPubMedCentral McAdams-Demarco MA, Tan J, Salter ML, Gross A, Meoni LA, Jaar BG, et al. Frailty and cognitive function in incident hemodialysis patients. Clin J Am Soc Nephrol. 2015;10:2181–9.CrossRefPubMedPubMedCentral
8.
go back to reference Wolfgram DF, Szabo A, Murray AM, Whittle J. Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit Dial Int. 2015;35:189–98.CrossRefPubMedPubMedCentral Wolfgram DF, Szabo A, Murray AM, Whittle J. Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit Dial Int. 2015;35:189–98.CrossRefPubMedPubMedCentral
9.
go back to reference Neumann D, Mau W, Wienke A, Girndt M. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course. Kidney Int. 2018;93:430–8.CrossRefPubMed Neumann D, Mau W, Wienke A, Girndt M. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course. Kidney Int. 2018;93:430–8.CrossRefPubMed
10.
go back to reference Tian X, Guo X, Xia X, Yu H, Li X, Jiang A. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e14390.CrossRefPubMed Tian X, Guo X, Xia X, Yu H, Li X, Jiang A. The comparison of cognitive function and risk of dementia in CKD patients under peritoneal dialysis and hemodialysis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019;98:e14390.CrossRefPubMed
11.
go back to reference Ali H, Soliman K, Mohamed MM, Daoud A, Shafiq T, Fülöp T, et al. The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure: a systematic review and meta-analysis. Int Urol Nephrol. 2021;53:155–63.CrossRefPubMed Ali H, Soliman K, Mohamed MM, Daoud A, Shafiq T, Fülöp T, et al. The effects of dialysis modality choice on cognitive functions in patients with end-stage renal failure: a systematic review and meta-analysis. Int Urol Nephrol. 2021;53:155–63.CrossRefPubMed
12.
go back to reference Kramer L, Madl C, Stockenhuber F, Yeganehfar W, Eisenhuber E, Derfler K, et al. Beneficial effect of renal transplantation on cognitive brain function. Kidney Int. 1996;49:833–8.CrossRefPubMed Kramer L, Madl C, Stockenhuber F, Yeganehfar W, Eisenhuber E, Derfler K, et al. Beneficial effect of renal transplantation on cognitive brain function. Kidney Int. 1996;49:833–8.CrossRefPubMed
13.
go back to reference Radić J, Ljutić D, Radić M, Kovačić V, Dodig-Ćurković K, Šain M. Kidney transplantation improves cognitive and psychomotor functions in adult hemodialysis patients. Am J Nephrol. 2011;34:399–406.CrossRefPubMed Radić J, Ljutić D, Radić M, Kovačić V, Dodig-Ćurković K, Šain M. Kidney transplantation improves cognitive and psychomotor functions in adult hemodialysis patients. Am J Nephrol. 2011;34:399–406.CrossRefPubMed
14.
go back to reference Griva K, Thompson D, Jayasena D, Davenport A, Harrison M, Newman SP. Cognitive functioning pre- to post-kidney transplantation—a prospective study. Nephrol Dial Transpl. 2006;21:3275–82.CrossRef Griva K, Thompson D, Jayasena D, Davenport A, Harrison M, Newman SP. Cognitive functioning pre- to post-kidney transplantation—a prospective study. Nephrol Dial Transpl. 2006;21:3275–82.CrossRef
15.
go back to reference Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Dębska-Ślizień A, Rutkowski B. Continuous cognitive improvement 1 year following successful kidney transplant. Kidney Int. 2011;79:1353–60.CrossRefPubMed Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Dębska-Ślizień A, Rutkowski B. Continuous cognitive improvement 1 year following successful kidney transplant. Kidney Int. 2011;79:1353–60.CrossRefPubMed
16.
go back to reference O’Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67:925–35.CrossRefPubMed O’Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, et al. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2016;67:925–35.CrossRefPubMed
17.
go back to reference Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216–23.CrossRefPubMed Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216–23.CrossRefPubMed
18.
go back to reference Kurella Tamura M, Larive B, Unruh ML, Stokes JB, Nissenson A, Mehta RL, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the frequent hemodialysis network trials. Clin J Am Soc Nephrol. 2010;5:1429–38.CrossRefPubMed Kurella Tamura M, Larive B, Unruh ML, Stokes JB, Nissenson A, Mehta RL, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the frequent hemodialysis network trials. Clin J Am Soc Nephrol. 2010;5:1429–38.CrossRefPubMed
19.
go back to reference Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRefPubMed Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRefPubMed
20.
go back to reference Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the montreal cognitive assessment. Geriatr Gerontol Int. 2010;10:225–32.CrossRefPubMed Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the montreal cognitive assessment. Geriatr Gerontol Int. 2010;10:225–32.CrossRefPubMed
21.
go back to reference Weiner DE, Scott TM, Giang LM, Agganis BT, Sorensen EP, Tighiouart H, et al. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58:773–81.CrossRefPubMedPubMedCentral Weiner DE, Scott TM, Giang LM, Agganis BT, Sorensen EP, Tighiouart H, et al. Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58:773–81.CrossRefPubMedPubMedCentral
22.
go back to reference Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y. Psychiatric disorders among patients undergoing hemodialysis therapy. Nephron. 2002;91:344–7.CrossRefPubMed Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y. Psychiatric disorders among patients undergoing hemodialysis therapy. Nephron. 2002;91:344–7.CrossRefPubMed
23.
go back to reference Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003;23:86–90.CrossRefPubMed Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T, et al. Silent cerebral infarction in hemodialysis patients. Am J Nephrol. 2003;23:86–90.CrossRefPubMed
24.
go back to reference Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Debska-Slizień A, Rutkowski B. Cognitive performance before and after kidney transplantation: a prospective controlled study of adequately dialyzed patients with end-stage renal disease. J Int Neuropsychol Soc. 2009;15:684–94.CrossRefPubMed Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Debska-Slizień A, Rutkowski B. Cognitive performance before and after kidney transplantation: a prospective controlled study of adequately dialyzed patients with end-stage renal disease. J Int Neuropsychol Soc. 2009;15:684–94.CrossRefPubMed
25.
go back to reference Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, et al. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008;87:106–13.CrossRefPubMed Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, et al. Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr. 2008;87:106–13.CrossRefPubMed
26.
go back to reference Nissenson AR, Marsh JT, Brown WS, Wolcott DL. Central nervous system function in dialysis patients: a practical approach. Semin Dial. 1991;4:115–23.CrossRef Nissenson AR, Marsh JT, Brown WS, Wolcott DL. Central nervous system function in dialysis patients: a practical approach. Semin Dial. 1991;4:115–23.CrossRef
27.
go back to reference Johnson WJ, McCarthy JT, Yanagihara T, Osmundson PJ, Ilstrup DM, Jenson BM, et al. Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability. Kidney Int. 1990;38:919–24.CrossRefPubMed Johnson WJ, McCarthy JT, Yanagihara T, Osmundson PJ, Ilstrup DM, Jenson BM, et al. Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability. Kidney Int. 1990;38:919–24.CrossRefPubMed
28.
go back to reference Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, et al. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO. Am J Physiol. 1992;262:F737–43.PubMed Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, et al. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO. Am J Physiol. 1992;262:F737–43.PubMed
29.
go back to reference Kanai H, Hirakata H, Nakane H, Fujii K, Hirakata E, Ibayashi S, et al. Depressed cerebral oxygen metabolism in patients with chronic renal failure: a positron emission tomography study. Am J Kidney Dis. 2001;38:S129–33.CrossRefPubMed Kanai H, Hirakata H, Nakane H, Fujii K, Hirakata E, Ibayashi S, et al. Depressed cerebral oxygen metabolism in patients with chronic renal failure: a positron emission tomography study. Am J Kidney Dis. 2001;38:S129–33.CrossRefPubMed
30.
go back to reference Kuwabara Y, Sasaki M, Hirakata H, Koga H, Nakagawa M, Chen T, et al. Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure. Kidney Int. 2002;61:564–9.CrossRefPubMed Kuwabara Y, Sasaki M, Hirakata H, Koga H, Nakagawa M, Chen T, et al. Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure. Kidney Int. 2002;61:564–9.CrossRefPubMed
31.
go back to reference Pereira AA, Weiner DE, Scott T, Sarnak MJ. Cognitive function in dialysis patients. Am J Kidney Dis. 2005;45:448–62.CrossRefPubMed Pereira AA, Weiner DE, Scott T, Sarnak MJ. Cognitive function in dialysis patients. Am J Kidney Dis. 2005;45:448–62.CrossRefPubMed
32.
go back to reference Himmelfarb J, Stenvinkel P, Ikizler A, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–38.CrossRefPubMed Himmelfarb J, Stenvinkel P, Ikizler A, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–38.CrossRefPubMed
33.
go back to reference Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int. 2001;59:407–14.CrossRefPubMed Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int. 2001;59:407–14.CrossRefPubMed
34.
go back to reference Madan P, Kalra OP, Agarwal S, Tandon OP. Cognitive impairment in chronic kidney disease. Nephrol Dial Transpl. 2007;22:440–4.CrossRef Madan P, Kalra OP, Agarwal S, Tandon OP. Cognitive impairment in chronic kidney disease. Nephrol Dial Transpl. 2007;22:440–4.CrossRef
35.
go back to reference Madan P, Agarwal S, Kalra OP, Tandon OP. Effect of hemodialysis on cognitive function in ESRD patients. Ren Fail. 2007;29:699–703.CrossRefPubMed Madan P, Agarwal S, Kalra OP, Tandon OP. Effect of hemodialysis on cognitive function in ESRD patients. Ren Fail. 2007;29:699–703.CrossRefPubMed
36.
go back to reference De Deyn PP, Vanholder R, Eloot S, Glorieux G. Guanidino compounds as uremic (neuro) toxins. Semin Dial. 2009;22:340–5.CrossRefPubMed De Deyn PP, Vanholder R, Eloot S, Glorieux G. Guanidino compounds as uremic (neuro) toxins. Semin Dial. 2009;22:340–5.CrossRefPubMed
37.
go back to reference Assem M, Lando M, Grissi M, Kamel S, Massy ZA, Chillon JM, et al. The impact of uremic toxins on cerebrovascular and cognitive disorders. Toxins (Basel). 2018;10:303.CrossRefPubMed Assem M, Lando M, Grissi M, Kamel S, Massy ZA, Chillon JM, et al. The impact of uremic toxins on cerebrovascular and cognitive disorders. Toxins (Basel). 2018;10:303.CrossRefPubMed
38.
go back to reference Yaffe K, Lindquist K, Shlipak MG, Simonsick E, Fried L, Rosano C, et al. Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol. 2008;63:798–802.CrossRefPubMedPubMedCentral Yaffe K, Lindquist K, Shlipak MG, Simonsick E, Fried L, Rosano C, et al. Cystatin C as a marker of cognitive function in elders: findings from the health ABC study. Ann Neurol. 2008;63:798–802.CrossRefPubMedPubMedCentral
39.
go back to reference Lindström V, Grubb A, Alquist Hegbrant M, Christensson A. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest. 2008;68:685–91.CrossRefPubMed Lindström V, Grubb A, Alquist Hegbrant M, Christensson A. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest. 2008;68:685–91.CrossRefPubMed
40.
go back to reference De Deyn PP, Robitaille P, Vanasse M, Qureshi IA, Marescau B. Serum Guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered Guanidino compound concentrations. Nephron. 1995;69:411–7.CrossRefPubMed De Deyn PP, Robitaille P, Vanasse M, Qureshi IA, Marescau B. Serum Guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered Guanidino compound concentrations. Nephron. 1995;69:411–7.CrossRefPubMed
Metadata
Title
Combining hemodialysis with peritoneal dialysis improves cognitive function: a three-case report
Authors
Tomomi Maruki
Takashin Nakayama
Kohkichi Morimoto
Kiyotaka Uchiyama
Naoki Washida
Ryunosuke Mitsuno
Shun Tonomura
Eriko Yoshida Hama
Ei Kusahana
Norifumi Yoshimoto
Akihito Hishikawa
Aika Hagiwara
Tatsuhiko Azegami
Jun Yoshino
Toshiaki Monkawa
Tadashi Yoshida
Shintaro Yamaguchi
Kaori Hayashi
Publication date
26-04-2024
Publisher
Springer Nature Singapore
Published in
CEN Case Reports
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-024-00880-4
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.